Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome

Journal of Endocrinological Investigation

Volumn 26, Issue 6, 2003, Pages 539-544

  Putignano, P ^a   Bertolini, M ^a   Losa, M ^b   Cavagnini, Francesco ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cushing's syndrome; Dexamethasone suppression test; Midnight plasma cortisol; Polycystyc ovary syndrome; Urinary free cortisol

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CIRCADIAN RHYTHM; COMPARATIVE STUDY; CONTROLLED STUDY; CUSHING SYNDROME; DATA ANALYSIS; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL RECORD; OBESITY; OVARY POLYCYSTIC DISEASE; POPULATION RESEARCH; PREMENOPAUSE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RETROSPECTIVE STUDY; SAFETY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; URINALYSIS;

EID: 0042024956     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345217     Document Type: Article

References (36)

1. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: A prospective study. J. Clin. Endocrinol. Metab. 1998, 83: 3078-3082.
2. Solomon C.G. The epidemiology and polycystic ovary syndrome. Endocrinol Metab. Clin. North Am. 1999, 28: 247-263.
3. Franks S. Polycystic ovary syndrome. N. Engl. J. Med. 1995, 333: 853-861.
4. Lado-Abeal J., Rodriguez-Arnao J., Newelll-Price J., et al. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. J. Clin. Endocrinol. Metab. 1998, 83: 3083-3088.
5. Kaltsas G.A., Korbonits M., Isidori A.M., et al. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? Clin. Endocrinol. (Oxf.) 2000, 53: 493-500.
6. Stewart P.M., Shackleton C., Beastall G.H., Edwards C.R. Alpha-reductase activity in polycystic ovary syndrome. Lancet 1990, 335: 431-433.
7. Invitti C., Giraldi F.P., Dubini S., De Martin M., Cavagnini F. Increased urinary free cortisol and decreased serum corticosteroid-binding globulin in polycystic ovary syndrome. Acta Endocrinol. (Copenh.) 1991, 125: 28-32.
8. Luppa P., Muller B., Jacob K., et al. Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: Evidence for an altered corticoid excretion. J. Clin. Endocrinol. Metab. 1995, 80: 280-288.
9. Invitti C., De Martin M., Delitala G., Veldhuis, J.D., Cavagnini F. Alterd morning and nighttime pulsatile corticotropine and cortisol release in polycystic ovary syndrome. Metabolism 1998, 47: 143-148.
10. Lanzone A., Petraglia F., Fulghesu A.M., Ciampelli M., Caruso A., Mancuso S. Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome. Fertil. Steril. 1995, 63: 1195-1199.
11. Atkinson A.B., McAteer E.J., Hadden D.R., Kennedy L., Sheridan B., Traub A.I. A weight-related intravenous dexamethasone suppression test distinguishes obese controls from patients with Cushing's syndrome. Acta Endocrinol. (Copenh.) 1989, 120: 753-759.
12. Chang R.J., Katz S.E. Diagnosis of polycystic ovary syndrome. Endocrinol. Metab. Clin. North Am. 1999, 28: 397-408.
13. Lin C.L., Wu T.J., Machacek D.A., Jiang, N.S., Kao P.C. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. J. Clin. Endocrinol. Metab. 1997, 82: 151-155.
14. Newell-Price, J., Trainer P., Besser M., Grossman A. The diagnosis and differential diagnosis of Cushing's Syndrome and Pseudo-Cushing's States. Endocr. Rev. 1998, 19: 647-672.
15. Invitti S., Pecori Giraldi F., De Martin M., Cavagnini F. The Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. Diagnosis and management of Cushing's syndrome: Results of an Italian multicentre study. J. Clin. Endocrinol. Metab. 1999, 84: 440-448.
16. Gorges R., Knappe G., Gerl H., Ventz M., Stahl F. Diagnosis of Cushing's syndrome: Re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression in a large patients group. J. Endocrinol. Invest. 1999, 22: 241-249.
17. Montwill J., Igoe D., McKenna T.J. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome. Steroids 1994, 59: 296-298.
18. Papanicolaou D.A., Yanovski J.A., Cutler G.B., Chrousos G.B., Nieman L.K. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J. Clin. Endocrinol. Metab. 1998, 83: 1163-1167.
19. Newell-Price J., Trainer P., Perry L., Wass J., Grossman A., Besser M. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin. Endocrinol. (Oxf.) 1995, 43: 545-550.
20. Nieman L.K. Cushing's syndrome. In: DeGroot L.J. (ed.), Endocrinology, ed. 4. W.B. Saunders, Philadelphia, 2000, p. 1691.
21. Zawadzki J.K, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A., Givens J.R., Haseltine F., Merrimam G.R. (Eds.), Polycystic Ovary Syndrome. Blackwell, Boston, 1992, p. 377.
22. Yanovski J.A., Cutler G.B. Jr., Chrousos G.P., Nieman L.K. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. J.A.M.A. 1993, 269: 2232-2238.
23. Moro M., Putignano P., Losa M., Invitti C., Marashini C., Cavagnini F. The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states. J. Clin. Endocrinol. Metab. 2000, 85: 3569-3574.
24. Meeran K., Hattersley A., Mould G., Bloom S.R. Venepuncture causes rapid rise in plasma ACTH. Brit. J. Clin. Pract. 1993, 47: 246-247.
25. Barry H.C., Ebell M.H. Test characteristics and decision rules. Endocrinol. Metab. Clin. North Am. 1977, 26: 45-65.
26. Swets J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240: 1285-1293.
27. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristics (ROC) curve. Radiology 1982, 143: 29-36.
28. Wood P.J., Barth J.H., Freedman D.B., Perry L., Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann. Clin. Biochem. 1997, 34: 222-229.
29. Talbott E., Guzick D., Clerici A., et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arter. Thromb. Vasc. Biol. 1995, 15: 821-826.
30. Rodin A., Thakkar H., Taylor N., Clayton R. Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase. N. Engl. J. Med. 1994, 330: 460-465.
31. Ehrmann D.A., Barnes R.B., Rosenfield R.L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr. Rev. 1995, 16: 322-353.
32. Kero J., Poutanen M., Zhang F.P., et al. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J. Clin. Invest. 2000, 105: 633-641.
33. Raff H., Raff J.L., Findling J.W. Late-night salivary cortisol as a screening test for Cushing's syndrome. J. Clin. Endocrinol. Metab. 1998, 83: 2681-2686.
34. Papanicolau D.A., Mullen N., Kyrou I., Nieman L.N. Nighttime salivary cortisol: A useful test for the diagnosis of Cushing's syndrome. J. Clin. Endocrinol. Metab. 2002 87: 4515-4521.
35. Putignano P., Kaltsas G.A., Satta M.A., Grossman A.B. The effect of anti-convulsant drugs on adrenal function. Horm. Metab. Res. 1998, 30: 389-397.
36. Kennedy L., Atkinson A.B., Johnston H., Sheridan B., Hadden D.R. Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing's syndrome. B.M.J. 1984, 289: 1188-1191.